摘要
目的探讨埃索美拉唑联合伊托必利治疗反流性食管炎临床疗效。方法采用回顾性分析的方法,分析我院收治的反流性食管炎患者临床资料,依据治疗方式不同分为对照组和观察组。结果观察组临床症状疗效和内镜疗效均明显高于对照组,P<0.05,差异均有统计学意义。结论埃索美拉唑联合伊托必利治疗反流性食管炎效果明显,预后良好,值得临床推广应用。
Objective To approach clinical curative effect of curing reflux esophagitis by Esomeprazole and Itopride.Method To retrospective analyze clinical data of curing reflux esophagitis,which was divided into control group and detection group.Result The curative effect of clinical symptom and endoscope of detection group were higher than control group（P0.05）,the difference were statistical significance.Conclusion The result of reflux esophagitis was obviously and eusemia by Esomeprazole and Itopride,which was to be used.
出处
《中国医药指南》
2012年第12期42-43,共2页
Guide of China Medicine
